PL3187178T3 - Kompozycja oraz leki do zmniejszania ilości zlokalizowanej tkanki tłuszczowej i masy ciała oraz ich zastosowanie - Google Patents

Kompozycja oraz leki do zmniejszania ilości zlokalizowanej tkanki tłuszczowej i masy ciała oraz ich zastosowanie

Info

Publication number
PL3187178T3
PL3187178T3 PL15836003.2T PL15836003T PL3187178T3 PL 3187178 T3 PL3187178 T3 PL 3187178T3 PL 15836003 T PL15836003 T PL 15836003T PL 3187178 T3 PL3187178 T3 PL 3187178T3
Authority
PL
Poland
Prior art keywords
pharmaceuticals
composition
body weight
localized fat
reducing localized
Prior art date
Application number
PL15836003.2T
Other languages
English (en)
Inventor
Yu-Fang Ling
Original Assignee
Caliway Biopharmaceuticals Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caliway Biopharmaceuticals Co. Ltd. filed Critical Caliway Biopharmaceuticals Co. Ltd.
Publication of PL3187178T3 publication Critical patent/PL3187178T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL15836003.2T 2014-08-28 2015-08-28 Kompozycja oraz leki do zmniejszania ilości zlokalizowanej tkanki tłuszczowej i masy ciała oraz ich zastosowanie PL3187178T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462042864P 2014-08-28 2014-08-28
PCT/CN2015/088340 WO2016029870A1 (zh) 2014-08-28 2015-08-28 用于减少局部脂肪与减少体重的组合物及其医药品与应用

Publications (1)

Publication Number Publication Date
PL3187178T3 true PL3187178T3 (pl) 2022-11-21

Family

ID=55398772

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15836003.2T PL3187178T3 (pl) 2014-08-28 2015-08-28 Kompozycja oraz leki do zmniejszania ilości zlokalizowanej tkanki tłuszczowej i masy ciała oraz ich zastosowanie

Country Status (18)

Country Link
US (1) US9987325B2 (pl)
EP (2) EP3187178B1 (pl)
JP (1) JP6473505B2 (pl)
KR (2) KR101859345B1 (pl)
CN (1) CN106604724B (pl)
AU (2) AU2015309353B2 (pl)
CA (1) CA2959185C (pl)
CY (1) CY1125384T1 (pl)
DK (1) DK3187178T3 (pl)
ES (1) ES2924879T3 (pl)
HU (1) HUE059878T2 (pl)
MX (2) MX385905B (pl)
PL (1) PL3187178T3 (pl)
PT (1) PT3187178T (pl)
SG (1) SG11201701476PA (pl)
SI (1) SI3187178T1 (pl)
TW (1) TWI580422B (pl)
WO (1) WO2016029870A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160129068A1 (en) * 2014-11-10 2016-05-12 Caliway Biomedical Co., Ltd. Composition of plant extract and its pharmaceutical composition and application thereof
US11318110B2 (en) 2015-08-28 2022-05-03 Caliway Biopharmaceuticals Co., Ltd. Pharmaceutical composition for reducing local fat and uses thereof
EP3381451B1 (en) * 2015-08-28 2025-08-20 Caliway Biopharmaceuticals Co., Ltd. Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition
CA3033041A1 (en) * 2016-08-26 2018-03-01 Caliway Biopharmaceuticals Co., Ltd. A subcutaneous injection formulation for reducing body weight and uses thereof
US10765718B2 (en) * 2017-02-02 2020-09-08 Golo Llc Formulations for weight loss and methods of use
KR102093872B1 (ko) 2017-07-03 2020-03-27 진호성 지방제거용 주사제 조성물 및 이의 제조방법
WO2025024299A1 (en) * 2023-07-21 2025-01-30 Arizona Board Of Regents On Behalf Of Arizona State University Resveratrol and quercetin-loaded nanoparticles and methods of use thereof
CN118286185B (zh) * 2024-03-14 2025-01-21 南京大学 一种用于局部减脂的双层可溶性微针贴片及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475530B1 (en) * 2000-05-31 2002-11-05 Eric H. Kuhrts Methods and compositions for producing weight loss
US20040146539A1 (en) * 2003-01-24 2004-07-29 Gupta Shyam K. Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits
US20050171027A1 (en) 2003-12-29 2005-08-04 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
ITFI20050031A1 (it) * 2005-02-21 2006-08-22 Stefan Coccoloni Una composizione farmaceutica atta a prevenire l'invecchiamento e l'insorgere di malattie vascolari,neoplastiche,cutanee e dell'apparato pilifero
WO2007041276A2 (en) 2005-09-29 2007-04-12 New Chapter, Inc. Methods for modulating apoptosis, cellgrowth, and protein expression with herbal compositions
JP2007131603A (ja) * 2005-11-14 2007-05-31 Kaneka Corp Ｌ−カルニチン合成系酵素遺伝子の転写促進用組成物
EP2001561A2 (en) * 2006-03-31 2008-12-17 DSMIP Assets B.V. Novel use of compounds and combinations of compunds for improving the physical appearance
US7977319B1 (en) 2006-04-03 2011-07-12 Scott David Levine Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
CN101095665A (zh) 2006-06-27 2008-01-02 中国科学院上海生命科学研究院 Sirt1在预防、控制或治疗肥胖中的用途
CN102357226B (zh) 2007-08-07 2013-07-10 北京北大维信生物科技有限公司 中草药姜黄的醇提取物在制备具有脂肪酶活性抑制作用的药物中的应用
WO2009146218A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
EP2348868A4 (en) 2008-10-22 2013-06-12 Metaproteomics Llc NEW MITOCHONDRIAL DECOMPOSITION PROCESSES AND COMPOSITIONS FOR IMPROVED THERMOGENESIS IN FAT CELLS
CN101632655B (zh) * 2009-08-04 2011-12-07 南京大渊美容保健有限公司 延缓衰老的白藜芦醇和生物类黄酮营养组合物
JP5594819B2 (ja) * 2009-12-22 2014-09-24 キリンホールディングス株式会社 脂質代謝改善用組成物
PH12012502423B1 (en) 2010-07-02 2018-01-12 Helix Biomedix Inc N-acyl amino acid derivatives for treating skin conditions such as cellulite
US8815310B2 (en) 2011-01-10 2014-08-26 Morteza Naghavi Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health
US9745279B2 (en) * 2011-12-27 2017-08-29 Tokiwa Phytochemical Co., Ltd. Sirtuin activator
US8496979B1 (en) 2012-02-02 2013-07-30 Reliv International, Inc. Caffeine-free dietary supplements for increasing energy and methods of administering the same
US8652518B2 (en) * 2012-04-15 2014-02-18 Jahahreeh Finley Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation
US9211298B2 (en) * 2012-11-16 2015-12-15 Song Gao Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
AU2015309351B2 (en) * 2014-08-28 2019-01-03 Caliway Biopharmaceuticals Co., Ltd. Composition and medicinal product for reducing body weight and body fat, and use of said product

Also Published As

Publication number Publication date
CN106604724B (zh) 2020-05-26
KR101935219B1 (ko) 2019-01-03
EP3187178A1 (en) 2017-07-05
EP3187178B1 (en) 2022-06-08
EP3811935A1 (en) 2021-04-28
CN106604724A (zh) 2017-04-26
TWI580422B (zh) 2017-05-01
JP2017525772A (ja) 2017-09-07
MX385905B (es) 2025-03-11
ES2924879T3 (es) 2022-10-11
AU2015309353A1 (en) 2017-03-16
SG11201701476PA (en) 2017-03-30
AU2015309353B2 (en) 2018-12-20
TW201707695A (zh) 2017-03-01
KR20170043657A (ko) 2017-04-21
EP3187178A4 (en) 2018-02-14
KR20180052785A (ko) 2018-05-18
CA2959185C (en) 2021-03-02
AU2019201635B2 (en) 2021-01-28
SI3187178T1 (sl) 2022-10-28
WO2016029870A1 (zh) 2016-03-03
CA2959185A1 (en) 2016-03-03
MX2017002585A (es) 2017-05-25
PT3187178T (pt) 2022-06-21
MX2021010638A (es) 2021-09-28
DK3187178T3 (da) 2022-08-22
US20170157193A1 (en) 2017-06-08
HUE059878T2 (hu) 2023-01-28
AU2019201635A1 (en) 2019-04-04
KR101859345B1 (ko) 2018-05-18
CY1125384T1 (el) 2025-05-09
JP6473505B2 (ja) 2019-02-20
US9987325B2 (en) 2018-06-05

Similar Documents

Publication Publication Date Title
IL247713A0 (en) Indazole 3-carboxyamides converted at the 5-position, their preparation and their use
GB201411197D0 (en) Composition and use thereof
IL261406A (en) Compositions and methods for modulating body weight
GB201403093D0 (en) Therapeutic compounds and their use
PL3018183T3 (pl) Kompozycja na bazie fluorowcoolefiny i jej zastosowanie
PL3187178T3 (pl) Kompozycja oraz leki do zmniejszania ilości zlokalizowanej tkanki tłuszczowej i masy ciała oraz ich zastosowanie
EP3187189A4 (en) Composition and medicinal product for reducing body weight and body fat, and use of said product
IL257392B (en) Pyrazolyl-substituted heteroaryls and their use as medicaments
IL283335B (en) Dihydropyrimidine-2-one compounds and their medical use
SG11201607600TA (en) Vaginal composition and use thereof
GB201403969D0 (en) Compounds for use in controlling body fat
GB201411196D0 (en) Composition and use thereof
PT3129398T (pt) Novos agentes médicos e usos dos mesmos
GB201406172D0 (en) Therapy and pharmaceutical composition
GB201418809D0 (en) Therapeutic agents and uses thereof
IL274868A (en) History of imidazopyridine and their use as medicine
DK3145548T3 (en) Aqueous gel composition and its use
GB201418541D0 (en) Materials for use with general hyperthermia treatment
IL251930B (en) Benzylhydroxy derivatives, their preparation and medical uses
GB201410387D0 (en) Compounds and their therapeutic use
GB201403496D0 (en) Compounds and their therapeutic use
GB201414103D0 (en) Solid products and their use